Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,330,117
  • Shares Outstanding, K 198,229
  • Annual Sales, $ 40 K
  • Annual Income, $ -21,820 K
  • 60-Month Beta 4.43
  • Price/Sales 31.72
  • Price/Cash Flow N/A
  • Price/Book 27.60
Trade OCGN with:

Options Overview

Details
  • Implied Volatility 140.59%
  • Historical Volatility 71.25%
  • IV Percentile 24%
  • IV Rank 14.89%
  • IV High 359.02% on 02/26/21
  • IV Low 102.36% on 07/29/21
  • Put/Call Vol Ratio 0.11
  • Today's Volume 19,739
  • Volume Avg (30-Day) 25,980
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 245,607
  • Open Int (30-Day) 315,181

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.03
  • Number of Estimates 3
  • High Estimate -0.03
  • Low Estimate -0.04
  • Prior Year -0.19
  • Growth Rate Est. (year over year) +84.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.11 +12.11%
on 07/15/21
8.29 -17.37%
on 07/06/21
-0.44 (-6.04%)
since 07/02/21
3-Month
5.96 +14.93%
on 06/14/21
16.20 -57.72%
on 05/03/21
-5.82 (-45.94%)
since 04/30/21
52-Week
0.25 +2,638.90%
on 11/02/20
18.77 -63.51%
on 02/08/21
+6.33 (+1,229.84%)
since 07/31/20

Most Recent Stories

More News
INVESTOR ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Ocugen, Inc. (OCGN) Investors

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired Ocugen, Inc....

OCGN : 6.85 (+2.09%)
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - OCGN

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Ocugen, Inc. (NASDAQ: OCGN) between February 2, 2021 and June 10, 2021, inclusive (the "Class Period"), of...

OCGN : 6.85 (+2.09%)
OCGN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of August 17, 2021 in the Class Action Filed on Behalf of Ocugen, Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - August 2, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) alleging that...

OCGN : 6.85 (+2.09%)
OCGN ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating Ocugen, Inc. (NASDAQ:OCGN) for Potential Securities Violations and Breach of Fiduciary Duty

NEW YORK, NY / ACCESSWIRE / August 2, 2021 / Labaton Sucharow, a nationally ranked and award-winning shareholder rights law firm, is investigating potential securities violations and breach of fiduciary...

OCGN : 6.85 (+2.09%)
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / August 2, 2021 / , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ('Ocugen' or 'the Company') (NASDAQ:OCGN)...

OCGN : 6.85 (+2.09%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Ocugen, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2021 - OCGN

New York, New York--(Newsfile Corp. - August 2, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:

OCGN : 6.85 (+2.09%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OCGN, HMPT and DIDI

NEW YORK, NY / ACCESSWIRE / August 2, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

OCGN : 6.85 (+2.09%)
HMPT : 5.15 (+3.41%)
DIDI : 10.38 (+0.68%)
INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Ocugen, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - August 2, 2021) - , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocugen" or "the Company")...

OCGN : 6.85 (+2.09%)
OCGN, TEDU & HMPT Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints...

OCGN : 6.85 (+2.09%)
TEDU : 1.9200 (-3.03%)
HMPT : 5.15 (+3.41%)
CLASS ACTION UPDATE for SRAC, OCGN and CRMD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / August 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

SRAC : 10.01 (+0.10%)
OCGN : 6.85 (+2.09%)
CRMD : 6.01 (+3.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 7.36
2nd Resistance Point 7.19
1st Resistance Point 7.02
Last Price 6.85
1st Support Level 6.68
2nd Support Level 6.51
3rd Support Level 6.34

See More

52-Week High 18.77
Fibonacci 61.8% 11.70
Fibonacci 50% 9.51
Fibonacci 38.2% 7.32
Last Price 6.85
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar